- Home
- APYX
as 07-05-2024 4:00pm EST
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | CLEARWATER |
| Market Cap: | 47.1M | IPO Year: | 1987 |
| Target Price: | $4.75 | AVG Volume (30 days): | 39.6K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $6.47 | Next Earning Date: | 08-08-2024 |
| Revenue: | $50,451,000 | Revenue Growth: | 14.25% |
| Revenue Growth (this year): | -2.58% | Revenue Growth (next year): | 9.22% |
Stock Insider Trading Activity of Apyx Medical Corporation (APYX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HILL MATTHEW C | APYX | Chief Financial Officer | Dec 12 '23 | Buy | $2.19 | 2,500 | $5,475.00 | 2,500 | SEC Form 4 |
| Goodwin Charles D. II | APYX | Chief Executive Officer | Nov 14 '23 | Buy | $1.57 | 50,000 | $78,500.00 | 90,000 | SEC Form 4 |
Latest Apyx Medical Corporation News
APYX Breaking Stock News: Dive into APYX Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Calculating The Fair Value Of Apyx Medical Corporation (NASDAQ:APYX)
PR Newswire
11 days ago
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
Newsfile
a month ago
Edge Total Intelligence Inc. Updates Status of MCTO
CNW Group
a month ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
GlobeNewswire
a month ago
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
GlobeNewswire
a month ago
The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
GlobeNewswire
a month ago
Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
CNW Group
a month ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
Share on Social Networks:
Disclaimer
The information presented on this page, "APYX Apyx Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.